PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
202.31%
Revenue growth above 1.5x 6617.T's 32.33%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
157.37%
Gross profit growth above 1.5x 6617.T's 27.15%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
9397.65%
EBIT growth above 1.5x 6617.T's 225.70%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
6731.65%
Operating income growth above 1.5x 6617.T's 202.92%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
2551.92%
Net income growth above 1.5x 6617.T's 278.53%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
2619.15%
EPS growth above 1.5x 6617.T's 278.46%. David Dodd would review if superior product economics or effective buybacks drive the outperformance.
2619.15%
Diluted EPS growth above 1.5x 6617.T's 278.46%. David Dodd would see if there's a robust moat protecting these shareholder gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-76.37%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
232.45%
Positive 5Y CAGR while 6617.T is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
157.40%
Positive 3Y CAGR while 6617.T is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-100.00%
Negative 10Y OCF/share CAGR while 6617.T stands at 0.00%. Joel Greenblatt would scrutinize managerial effectiveness and product competitiveness.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
111.29%
Below 50% of 6617.T's 227.22%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
548.37%
5Y net income/share CAGR above 1.5x 6617.T's 227.22%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
159.94%
3Y net income/share CAGR 1.25-1.5x 6617.T's 111.64%. Bruce Berkowitz might see new markets, M&A, or better cost discipline driving the difference.
-55.85%
Negative equity/share CAGR over 10 years while 6617.T stands at 3.73%. Joel Greenblatt sees a fundamental red flag unless the competitor also struggles.
60.52%
5Y equity/share CAGR above 1.5x 6617.T's 3.73%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
36.36%
3Y equity/share CAGR above 1.5x 6617.T's 4.21%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
34.79%
AR growth well above 6617.T's 30.52%. Michael Burry fears inflated revenue or higher default risk in the near future.
-46.20%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
-18.86%
Negative asset growth while 6617.T invests at 3.12%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
11.64%
BV/share growth above 1.5x 6617.T's 3.61%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-36.17%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
298.15%
R&D growth of 298.15% while 6617.T is zero. Bruce Berkowitz checks if the moderate investment leads to meaningful product differentiation.
15.55%
We expand SG&A while 6617.T cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.